Preliminary studies reveal conolidine may possibly inhibit specific ion channels, cutting down neuronal excitability and limiting soreness alerts. This mechanism is particularly suitable in neuropathic suffering, wherever abnormal signaling leads to persistent irritation. Additionally, conolidine appears to affect G protein-coupled receptor (GPCR)